Latest News for: vegf

Edit

Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)

PR Newswire 25 Feb 2026
JS207, Junshi Biosciences' independently developed recombinant humanized anti-PD-1/VEGF bispecific antibody, has demonstrated promising anti-tumor activity and a manageable safety profile in both preclinical and clinical studies.
Edit

Aggiornamento scheda Multifarmaco di monitoraggio semplificato intravitreali anti VEGF - RANIVISIO (Italian Medicines Agency)

Public Technologies 17 Feb 2026
) Si informano gli utenti dei Registri dei Farmaci sottoposti a Monitoraggio che, a seguito dell'entrata in vigore della Determina AIFA n ... Trattamento della degenerazione maculare neovascolare [...].
Edit

CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to ...

The Ridgway Record 16 Feb 2026
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has ...
Edit

CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial

PR Newswire 16 Feb 2026
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S ... SUZHOU, China, Feb. 15, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX ... About CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody).
Edit

Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific ...

Nasdaq Globe Newswire 05 Jan 2026
CR-001 IND cleared by U.S.
  • 1

Article Search

tools
×
×
×
×